Antidepressant profile of ptychopetalum olacoides bentham (marapuama) in mice

Phytotherapy Research

Volumn 23, Issue 4, 2009, Pages 519-524

  Piato, Ǎngelo L ^a   Rizon, Lucas P ^a   Martins, Bárbara S ^a   Nunes, Domingos S ^b   Elisabetsky, Elaine ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^c Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

Author keywords

Antidepressant; Catecholamine; Marapuama; Muirapuama; Ptychopetalum olacoides; Serotonin

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; FENCLONINE; FLUOXETINE; IMIPRAMINE; METIROSINE; NORADRENALIN; PLANT EXTRACT; PROPRANOLOL; PTYCHOPETALUM OLACOIDES EXTRACT; SEROTONIN; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE SYNTHESIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FORCED SWIMMING TEST; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OLACACEAE; PTYCHOPETALUM OLACOIDES; SYMPTOM; ANIMAL; CHEMISTRY; IMMOBILIZATION; MOTOR ACTIVITY; PLANT ROOT; SWIMMING;

MUS; PTYCHOPETALUM OLACOIDES;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB SUSPENSION; MALE; MICE; MOTOR ACTIVITY; NOREPINEPHRINE; OLACACEAE; PLANT EXTRACTS; PLANT ROOTS; SEROTONIN; SWIMMING;

EID: 64549126085     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2664     Document Type: Article

References (31)

1. Bilia AR, Gallori S, Vincieri FF. 2002. St. John's wort and depression: efficacy, safety and tolerability-an update. Life Sci 70: 3077-3096.
2. Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G. 2002. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol 12: 461-475.
3. Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H. 2002. Flavonoids from Hypericum perforatum show antidepres- sant activity in the forced swimming test. Planta Med 66: 3-6.
4. Cervo L, Mennini T, Rozio M, Ekalle-Soppo CB, Canetta A, Burbassi S, Guiso G, Pirona L, Riva A, Morazzoni P, Caccia S, Gobbi M. 2005. Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin. Eur Neuropsychopharmacol 15: 211-218.
5. da Silva AL, Piato AL, Ferreira JG, Martins BS, Nunes DS, Elisabetsky E. 2007. Promnesic effects of Ptychopetalum olacoides in aversive and non-aversive learning paradigms. J Ethnopharmacol 12: 449-457.
6. D'Aquila PS, Collu M, Pani L, Gessa GL, Serra G. 1994. Antidepressant-like effect of selective D1 receptor agonist in the behavioural despair animal model of depression. Eur J Pharmacol 262: 107-111.
7. D'Aquila PS, Collu M, Gessa GL, Serra G. 2000. The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405: 365-373.
8. De Montis MG, Gambarana C, Meloni D. 1993. Alpha-methyl-para-tyrosine antagonizes the effect of chronic imipramine on learned helplessness in rats. Eur J Pharmacol 249: 179-183.
9. Dunlop BW, Nemeroff CB. 2007. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64: 327-337.
10. Elisabetsky E, Siqueira IR. 1998. Is there a psychopharmacological meaning for traditional tonics? In Plants for Food and Medicine, Prendergast HDV, Etkin NL, Harris DR, Houghton PJ (eds). Kew: Royal Botanical Gardens; 373-385.
11. Gambarana C, Ghiglieri O, Tagliamonte A, Dalessandro N, De Montis MG. 1995. Crucial Role of D1 dopamine receptor in mediating the antidepressant effect of imipramine. Pharmacol Biochem Behav 2: 147-151.
12. Golden RN, Markey SP, Risby ED, Cowdry RW, Potter WZ. 1988. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. Arch Gen Psychiatry 45: 150-154.
13. Healy D. Did regulators fail over selective serotonin reuptake inhibitors? 2006. BMJ 333: 92-95.
14. Jain NN, Ohal CC, Shroff SK, Bhutada RH, Somani RS, Kasture VS, Kasture SB. 2003. Clitoria ternatea and the CNS. Pharmacol Biochem Behav 75: 529-536.
15. Mancinelli A, D'Aranno V, Stasi MA, Lecci A, Borsini F, Meli A. 1991. Effects of enantiomers of propranolol on desipramine-induced anti-immobility in the forced swimming test in the rat. Pharmacol Res 23: 47-50.
16. Miller HL, Ekstrom RD, Mason GA, Lydiard RB, Golden RN. 2001. Noradrenergic function and clinical outcome in anti-depressant pharmacotherapy. Neuropsychopharmacology 24: 617-23.
17. Reis de Oliveria I, Diquet B, Van der Meersch V, Dardennes R, Gonidec J, do Prado-Lima PA. 1990. Self-inhibiting action of nortriptyline's anti-immobility effect at high plasma and brain levels in mice. Psychopharmacology 102: 553-556.
18. Renard CE, Fiocco AJ, Clenet F, Hascoet M, Bourin M. 2001. Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology 159: 42-50.
19. Rodrigues AL, da Silva GL, Mateussi AS, Fernandes ES, Miguel OG, Yunes RA, Calixto JB, Santos AR. 2002. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci. 70: 1347-1358.
20. Rojas-Corrales MO, Gibert-Rahola J, Mico JA. 1998. Tramadol induces antidepressant-type effects in mice. Life Sci 63: 175-180.
21. Sairam K, Dorababu M, Goel RK, Bhattacharya SK. 2002. Anti- depressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine 9: 207-211.
22. Siqueira IR, Lara DR, Silva D, Gaieski FS, Nunes DS, Elisabetsky E. 1998. Psychopharmacological properties of Ptychopetalum olacoides BENTHAM (Olacacea). Pharm Biol 36: 327-334.
23. Siqueira IR, Cimarosti H, Fochesatto C, Nunes DS, Salbego C, Elisabetsky E, Netto CA. 2004. Neuroprotective effects of Ptychopetalum olacoides Bentham (Olacaceae) on oxygen and glucose deprivation induced damage in rat hippocampal slices. Life Sci 75: 1897-1906.
24. Siqueira IR, Fochesatto C, Torres IL, da Silva AL, Nunes DS, Elisabetsky E, Netto CA. 2007. Antioxidant activities of the ethanol extract from Ptychopetalum olacoides in mice brain. Phytomedicine 14: 763-769.
25. Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressant in mice. Psychopharmacology 85: 367-370.
26. Suhara TK, Nakayama O, Inoue HF, Shimizu AM, Tateno Y. 1992. D1 dopamine receptor-binding in mood disorders measured by positron emission tomography. Psychopharmacology 106: 14-18.
27. Sunal R, Gumusel B, Kayaalp SO. 1994. Effect of changes in swimming area on results of 'Behavioural Despair Test'. Pharmacol Biochem Behav 49: 891-896.
28. Willner P. 1990. Animal models of depression: an overview. Pharmacol Ther 45: 425-455.
29. Wong Ma-Li, Licinio J. 2001. Research and treatment approaches to depression. Nat Rev Neurosci 2: 343-351.
30. Yamada J, Sugimoto Y, Yamada S. 2004. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 504: 207-211.
31. Zomkowski AD, Rosa AO, Lin J, Santos AR, Calixto JB, Rodrigues AL. 2004. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in mouse forced swimming test. Brain Res 1023: 253-263.